Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03872245Phase 3Unknown
Phase 3, randomised, open-label trial in obesity (2 arms), sponsored by Hospital General Universitario de Elche. Primary endpoint: Weight loss at 10 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03872245.